AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Clin Nutr 89: 290-296, 2009. First published December 3, 2008; doi:10.3945/ajcn.2008.26709
American Journal of Clinical Nutrition, doi:10.3945/ajcn.2008.26709
Vol. 89, No. 1, 290-296, January 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow All Versions of this Article:
89/1/290    most recent
ajcn.2008.26709v1
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Landberg, R.
Right arrow Articles by Kamal-Eldin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Landberg, R.
Right arrow Articles by Kamal-Eldin, A.
Agricola
Right arrow Articles by Landberg, R.
Right arrow Articles by Kamal-Eldin, A.
© 2009 American Society for Clinical Nutrition

ORIGINAL RESEARCH COMMUNICATION

Dose response of whole-grain biomarkers: alkylresorcinols in human plasma and their metabolites in urine in relation to intake1,2,3

Rikard Landberg, Per Åman, Lena E Friberg, Bengt Vessby, Herman Adlercreutz and Afaf Kamal-Eldin

1 From the Department of Food Science, Swedish University of Agriculture Science, Uppsala, Sweden (RL, PÅ, and AK-E); the Department of Pharmaceutical Biosciences, Division of Pharmacokinetics and Drug Therapy, University of Uppsala, Uppsala, Sweden (LEF); the Department of Public Health & Caring Science and Geriatrics, Unit of Clinical Nutrition and Metabolism, University of Uppsala, Uppsala, Sweden (BV); and the Institute for Preventive Medicine, Nutrition and Cancer, Folkhälsan Research Center and Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland (HA).

2 Supported by the Swedish Governmental Agency for Innovation Systems; the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; the Swedish Nutrition Foundation; the Richard and Stina Högbergs Foundation; and the Sigrid Jusélius Foundation, Helsinki, Finland. The rye bran flakes were kindly provided by Lantmännen AB.

3 Reprints not available. Address correspondence to R Landberg, Department of Food Science, Swedish University of Agriculture Science, Box 7051, SE-75007, Uppsala, Sweden. E-mail: rikard.landberg{at}lmv.slu.se.

Background: Alkylresorcinols (ARs), phenolic lipids almost exclusively present in the outer parts of wheat and rye grains in commonly consumed foods, have been proposed as specific dietary biomarkers of whole-grain wheat and rye intakes.

Objective: The objective was to assess the dose response of plasma ARs and the excretion of 2 recently discovered AR metabolites in 24-h urine samples in relation to AR intake and to establish a pharmacokinetic model for predicting plasma AR concentration.

Design: Sixteen subjects were given rye bran flakes containing 11, 22, or 44 mg total ARs 3 times daily during week-long intervention periods separated by 1-wk washout periods in a nonblinded randomized crossover design. Blood samples were collected at baseline, after the 1-wk run-in period, and after each treatment and washout period. Two 24-h urine samples were collected at baseline and after each treatment period.

Results: Plasma AR concentrations and daily excretion of 2 urinary AR metabolites increased with increasing AR dose (P < 0.001). Recovery of urinary metabolites in 24-h samples decreased with increasing doses from {approx}90% to {approx}45% in the range tested. A one-compartment model with 2 absorption compartments with different lag times and absorption rate constants adequately predicted plasma AR concentrations at the end of each intervention period.

Conclusion: Both plasma AR concentrations and urinary metabolites in 24-h samples showed a dose-response relation to increased AR intake, which strongly supports the hypothesis that ARs and their metabolites may be useful as biomarkers of whole-grain wheat and rye intakes.




This article has been cited by other articles:


Home page
J. Nutr.Home page
R. Landberg, A. Kamal-Eldin, S.-O. Andersson, J.-E. Johansson, J.-X. Zhang, G. Hallmans, and P. Aman
Reproducibility of Plasma Alkylresorcinols during a 6-Week Rye Intervention Study in Men with Prostate Cancer
J. Nutr., May 1, 2009; 139(5): 975 - 980.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The American Society for Nutrition